Unusual 11 Mid-Day Movers 9/22: BSDM, FTBK, CHIP, KSW Higher; LIME, DDRX, FMAR, CRXX Lower

September 22, 2009 12:53 PM EDT

BSD Medical Corporation (NASDAQ: BSDM) 132.5% HIGHER; reports that significant and "medical practice changing" clinical study results were the subject of a news briefing at Europe's largest cancer congress, ECCO15 - ESMO34, which is being held September 20 to 24, 2009, in Berlin, Germany.

Frontier Financial (Nasdaq: FTBK) 45% HIGHER; continuing to break out above its 200-day smooth moving average today. The stock rallied more than 53% yesterday on extremely heavy volume.

VeriChip (Nasdaq: CHIP) 31.1% HIGHER; seeing follow-through momentum today amid news yesterday that the company was granted exclusive license for patents used in virus triage detection system for H1N1 virus. The stock jumped nearly 150% yesterday.

KSW, Inc. (NASDAQ: KSW) 19.7% HIGHER; today announced that a Joint Venture between the Company and Five Star Electrical Corp. has received the formal Notice of Award of the contract for the new World Trade Center Chiller Plant from the Port Authority of New York and New Jersey. The total amount of the contract is $46,190,000. KSW will be responsible for the mechanical portion of the Contract, while Five Star will be responsible for the electrical work. The companies will share in the balance of the contract.

Arbor Realty Trust (NYSE: ABR) 19.5% HIGHER; shares are rallying today following news after the close yesterday that an insider made some purchases: a Director, William Helmreich, purchased 40,000 shares on 9/17-9/18 at prices ranging from $2.39-$2.52, bringing his stake to 130,100 shares.

Lime Energy Co. (Nasdaq: LIME) 17.7% LOWER; announced the pricing of its public offering of 5,000,000 shares of its common stock at $5.50 per share, before the underwriting discount. The Company has granted the underwriters a 30 day option to purchase up to an additional 750,000 shares of the Company's common stock to cover over-allotments, if any. The Company expects to receive net proceeds of approximately $25.45 million after underwriting discounts and commissions and estimated offering expenses, exclusive of any exercise of the underwriters' over-allotment option, and intends to use the proceeds to repay indebtedness and for working capital and general corporate purposes.

Dana Holding Corporation (NYSE: DAN) 17.4% HIGHER; today announced that it has initiated an underwritten, registered public offering of 27 million shares of its common stock. In conjunction with the offering, Dana intends to grant the underwriters a 30-day option to purchase up to 4 million additional shares. Goldman, Sachs & Co. is serving as the sole book-runner, with Citi and J.P. Morgan as co-managers for the offering. The company intends to use the net proceeds from the offering for general corporate purposes including flexibility for future expansion and restructuring of operations.

Diedrich Coffee, Inc. (Nasdaq: DDRX) 16.6% LOWER; reports Q4 adj-EPS of $0.29, compared to an adj-loss of $0.37 in the same quarter last year. Revenue for the quarter was $20.1 million, versus $12.9 million in Q408. Sees FY10 sales of $90-$95 million, up 44-52% over FY09. GAAP EPS for the year are expected to be $0.90-$1.00.

First Mariner Bancorp (Nasdaq: FMAR) 15.7% LOWER; First Mariner Bank, the wholly-owned bank subsidiary of First Mariner Bancorp reports that it has agreed with the FDIC and The Maryland Division of Financial Regulation to the entry of an Order to Cease and Desist, dated and effective September 18, 2009, which directs the Bank to increase its capitalization, improve earnings, reduce non-performing loans, strengthen management policies and practices, and reduce reliance on non-core funding.

CombinatoRx, Incorporated (NASDAQ: CRXX) 13.9% LOWER; CombinatoRx and Neuromed Pharmaceuticals, Inc. announced that the U.S. FDA has posted on its website briefing documents for the September 23, 2009 joint meeting of its Anesthetics and Life Support Advisory Committee and its Drug Safety and Risk Management Advisory Committee. At the meeting, the committees will review and discuss Neuromed’s New Drug Application for Exalgo™ (hydromorphone HCI extended release) tablets seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

Delta Petroleum (Nasdaq: DPTR) 11.3% LOWER; continuing lower following yesterday's 45% plunge on disappointing well results.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• JPMorgan
• Citi
• Unusual 11 Mid-Day Movers
• FDIC

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?